본문 바로가기

The association of lung function changes with outcomes in children with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q1
저널
PEDIATRIC PULMONOLOGY56(10) · pp.3332 · 2021
피인용
Web of Science 8Scopus 11
FWCI (Scopus)
0.6
JCR IF
JCR 2020 3.039
ISSN
8755-6863

저자

  1. 정성수제1저자Pusan Natl Univ, Sch Med, Childrens Hosp, Dept Pediat, Yangsan, South Korea
  2. Yoon, Hee MangUniv Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea
  3. Yoon, JisunMediplex Sejong Hosp, Dept Pediat, Incheon, South Korea
  4. Park, MinjeeUniv Ulsan, Coll Med, Asan Med Ctr, Dept Pediat, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
  5. Rhee, Eun SangUniv Ulsan, Coll Med, Asan Med Ctr, Dept Pediat, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
  6. Kim, HyeryUniv Ulsan, Coll Med, Asan Med Ctr, Dept Pediat, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
  7. Koh, Kyung NamUniv Ulsan, Coll Med, Asan Med Ctr, Dept Pediat, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
  8. Lee, Jin SeongUniv Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea
  9. Im, Ho Joon교신저자Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pediat, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
  10. Yu, Jinho교신저자Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pediat, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea

초록

Background Bronchiolitis obliterans syndrome (BOS) is a life-threatening respiratory complication of allogeneic hematopoietic stem cell transplantation (HSCT). Although pulmonary function testing is crucial for monitoring BOS, little information exists on the association of these test results with outcomes in children with BOS. Objectives The purpose of this study was to determine the correlation between changes in lung function after BOS diagnosis and long-term outcomes. Methods A total of 428 children underwent allogeneic HSCT from January 2006 to December 2017 at Asan Medical Center. Twenty-three (5.4%) were diagnosed with BOS after allogeneic HSCT, and their clinical data were reviewed. Twenty-one subjects underwent regular pulmonary function testing for 24 months after BOS diagnosis. Results Among the 21 children with BOS, 8 died, 5 underwent lung transplantation (TPL), and 15 required oxygen (O-2) therapy. The FEV1% predicted (pred), FVC% pred, and FEF25%-75% pred were 37.8 +/- 12.7% (mean +/- SD), 62.2 +/- 16.2%, and 16.4 +/- 9.6%, respectively, at the time of BOS diagnosis. Changes in the FEV1% pred were greater in the death and lung TPL groups (-24.8 +/- 22.3%) than in the survival without lung TPL group (5.7 +/- 21.8%) and greater in the O-2 therapy (-19.4 +/- 23.4%) group than in the group without O-2 therapy (14.2 +/- 20.0%) during the first 3 months after BOS diagnosis. Conclusion The change in FEV1 during the first 3 months after BOS diagnosis correlated with outcomes including survival, lung TPL, and O-2 therapy. These results suggest that more active intervention in the first 3 months after BOS diagnosis may be needed to improve prognosis.

키워드

bronchiolitis obliteranschildrenpulmonary functionVERSUS-HOST-DISEASECONSENSUS DEVELOPMENT PROJECTRISK-FACTORSPULMONARY COMPLICATIONSCLINICAL-TRIALSDIAGNOSISONSETPATHOGENESISSURVIVALCRITERIA

식별자

Scopus EID
2-s2.0-85112821746
WoS UID
000685790400001